Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer Achieves Double Firsts With AAHRPP Status For Phase I Trials In Singapore

This article was originally published in PharmAsia News

Executive Summary

SINGAPORE - Pfizer became the first pharma company to be accredited by the U.S.-based Association for the Accreditation of Human Research Protection Programs for its Phase I Clinical Research Unit in Singapore
Advertisement

Related Content

Singapore, UK Award Infectious Disease Research Grants As Singapore Continues To Build Biomedical Research Base
Singapore, UK Award Infectious Disease Research Grants As Singapore Continues To Build Biomedical Research Base
Compounds Discovered In Asia Expected To Enter Clinic In Three Years, Pfizer Says
Compounds Discovered In Asia Expected To Enter Clinic In Three Years, Pfizer Says
Compounds Discovered In Asia Expected To Enter Clinic In Three Years, Pfizer Says
Compounds Discovered In Asia Expected To Enter Clinic In Three Years, Pfizer Says
Advertisement
UsernamePublicRestriction

Register

SC070239

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel